vitamin D supplementation: one bounded, context-dependent signal across receipts

Source literature boundary memo

Research question

Across retrieved fact-level receipts for vitamin D supplementation, which endpoints show directionally favorable versus null/non-convergent signals, and what matched PICO remains untested?

Selection criteria

The source-literature fallback selected vitamin D supplementation because the domain snapshot exposed enough fact-backed, topic-overlapping papers. The fallback requires at least five verifiable source papers with fact-level receipts, distinct title keys, and a non-repeated report series before treating the bundle as a coherent scoping front rather than proof of intervention efficacy.

Boundary map

• Whey Protein Supplementation with or without Vitamin D on Sarcopenia-Related Measures: A Systematic Review and Meta-Analysis [review; 2023] doi:10.1016/j.advnut.2023.05.011
  • Finding: whey protein supplementation significantly improved appendicular lean mass and physical function (SMD = 1.211; 95% CI: 0.588, 1.834; n = 16)
  • Population: sarcopenic/frail older adults
  • Intervention/exposure: whey protein supplementation
  • Comparator: control
• The Effects of Vitamin D Supplementation on Metabolic and Oxidative Stress Markers in Patients With Type 2 Diabetes: A 6-Month Follow Up Randomized Controlled Study [primary; 2021] doi:10.3389/fendo.2021.610893
  • Finding: significant decrease in advanced oxidation protein products levels over the 3-month period when higher vitamin D doses are given
  • Population: Patients with type 2 diabetes on standard metformin therapy
  • Intervention/exposure: Vitamin D supplementation (higher doses)
  • Comparator: Metformin only
• Effect of High-Dose vs Standard-Dose Vitamin D₃ Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer [primary; 2019] doi:10.1001/jama.2019.2402
  • Finding: at first restaging, 32.0 ng/mL vs 18.7 ng/mL (difference, 12.8 ng/mL [95% CI, 9.0 to 16.6], P < .001)
  • Population: patients with advanced or metastatic colorectal cancer
  • Intervention/exposure: high-dose vitamin D3
  • Comparator: standard-dose vitamin D3
• Impact of Vitamin D Supplementation on Influenza Vaccine Response and Immune Functions in Deficient Elderly Persons: A Randomized Placebo-Controlled Trial [primary; 2019] doi:10.3389/fimmu.2019.00065
  • Finding: The Th1/Th2 ratio was lower in the D group at V2 (D: 0.12 ± 0.05 vs. P: 0.18 ± 0.05, p = 0.039).
  • Population: Vitamin D deficient elderly persons (serum 25-(OH)D <30 ng/mL)
  • Intervention/exposure: 100,000 IU/15 days cholecalciferol for 3 months
  • Comparator: placebo (0.18 ± 0.05)
• The Effect of Vitamin D Supplementation on Glycemic Control in Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis [review; 2018] doi:10.3390/nu10030375
  • Finding: Vitamin D supplementation resulted in a significant improvement in serum 25(OH)D levels (weighted mean difference (WMD) = 33.98; 95%CI: 24.60-43.37)
  • Population: Type 2 diabetes patients
  • Intervention/exposure: Vitamin D supplementation
  • Comparator: Placebo or control

Source synthesis

This receipt-backed scoping note has one bounded signal: vitamin D supplementation shows context-dependent, not uniformly convergent associations across this 5-source primary/review bundle (2018-2023). Grouped by direction, directionally favorable: 2 receipt(s) | other/mixed: 3 receipt(s). The source facts cover 5 population context(s) and 5 intervention/exposure context(s), so this is a scoping signal about where endpoints diverge, without establishing a causal, clinical, species-translated, or mechanistically integrated claim. Concrete source-level examples: whey protein supplementation significantly improved appendicular lean mass and physical function (SMD = 1.211; 95% CI: 0.588, 1.834; n = 16); significant decrease in advanced oxidation protein products levels over the 3-month period when higher vitamin D doses are given; at first restaging, 32.0 ng/mL vs 18.7 ng/mL (difference, 12.8 ng/mL [95% CI, 9.0 to 16.6], P < .001).

Directional grouping

• directionally favorable: Whey Protein Supplementation with or without Vitamin D on Sarcopenia-Related Measures: A Systematic Review and Meta-Analysis — whey protein supplementation significantly improved appendicular lean mass and physical function (SMD = 1.211; 95% CI: 0.588, 1.834; n = 16)
• other/mixed: The Effects of Vitamin D Supplementation on Metabolic and Oxidative Stress Markers in Patients With Type 2 Diabetes: A 6-Month Follow Up Randomized Controlled Study — significant decrease in advanced oxidation protein products levels over the 3-month period when higher vitamin D doses are given
• other/mixed: Effect of High-Dose vs Standard-Dose Vitamin D₃ Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer — at first restaging, 32.0 ng/mL vs 18.7 ng/mL (difference, 12.8 ng/mL [95% CI, 9.0 to 16.6], P < .001)
• directionally favorable: Impact of Vitamin D Supplementation on Influenza Vaccine Response and Immune Functions in Deficient Elderly Persons: A Randomized Placebo-Controlled Trial — The Th1/Th2 ratio was lower in the D group at V2 (D: 0.12 ± 0.05 vs. P: 0.18 ± 0.05, p = 0.039).
• other/mixed: The Effect of Vitamin D Supplementation on Glycemic Control in Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis — Vitamin D supplementation resulted in a significant improvement in serum 25(OH)D levels (weighted mean difference (WMD) = 33.98; 95%CI: 24.60-43.37)

Specific moderators in this bundle are population/indication (Patients with type 2 diabetes on standard metformin therapy; Type 2 diabetes patients; Vitamin D deficient elderly persons (serum 25-(OH)D <30 ng/mL); patients with advanced or metastatic colorectal cancer; sarcopenic/frail older adults), study design/evidence type (primary/review). Single primary-study estimates are separated from pooled review or meta-analytic estimates rather than treated as interchangeable.

Context separation

The selected receipts group because each carries a fact-level extraction for vitamin D supplementation; they separate by context (human clinical/observational and other source context) and endpoint, so they are not interchangeable evidence for one pooled claim.

Boundary limits

Source-literature boundary for vitamin D supplementation: the listed sources define one bounded, context-dependent signal across separate source contexts. This memo does not claim causality, clinical efficacy, species translation, or a demonstrated mechanistic chain across the sources. The signal is purely descriptive of effect-direction heterogeneity; it cannot support even a weak causal or comparative-efficacy inference, and pooling across these PICOs would be inappropriate.

Next gaps

A stronger memo needs one matched PICO, for example: population=sarcopenic/frail older adults; intervention/exposure=whey protein supplementation; comparator=control; outcome=one named clinical endpoint. If vitamin D supplementation is promoted beyond a scoping note, the next run should select sources sharing one context family rather than mixing human clinical/observational and other source context.